3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
24
Lung Neoplasms
12
Neoplasms
5
Colorectal Neoplasms
5
Neoplasm Metastasis
4
Advanced Solid Tumors
3
Pancreatic Neoplasms
2
Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
2
Venous Thromboembolism
1
Thoracic Neoplasms
1
Solid Tumor, Adult
1
Solid Tumor
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Ovarian Neoplasms
1
Noonan Syndrome
1
Non-small Cell Lung Cancer Metastatic
1
Non Small Lung Cancer
1
Neoplasms by Site
1
Mesothelioma
1
Lung Diseases
1
KRAS p.G12C Mutant Advanced Solid Tumors
1
KRAS p, G12c Mutated /Advanced Metastatic NSCLC
1
Hereditary Sensory and Autonomic Neuropathies
1
Healthy Participants
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Efficacy
1
Carcinoma
1
Bronchial Neoplasms
1
Interventions
osimertinib
2
sotorasib
1
pembrolizumab
1
nazartinib
1
cobimetinib
1
Waiting Lists
1
Lovastatin
1
Lamotrigine
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Noonan Syndrome
×
sotorasib
×
Clear all
NCT04959981
2023-07-25
HERKULES-2
Erasca, Inc.
Phase 1
Completed
24 enrolled